Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
LOPRESSOR
Generic name / active ingredient
metoprolol tartrate
Dosage-form class
The current U.S. NDA 218698 product is an unscored, film-coated immediate-release metoprolol tartrate 12.5 mg tablet, supplied in bottles of 30, 60 and 1,000 tablets. It must not be combined or converted with historical 50/100 mg tablets, LOPRESSOR oral solution, LOPRESSOR HCT, injection or TOPROL-XL extended-release tablets.
Route
Oral
Record reviewed
2026-09-04

Copy from the pack in hand

Source-linked reading points

  • The 12.5 mg figure is the labelled amount per tablet, while 30, 60 or 1,000 is the bottle count. None answers an individual's daily tablet count, splitting question or conversion to another metoprolol product.
  • The label describes this tablet as unscored. That alone does not let a webpage declare that splitting is always prohibited or acceptable; use the exact pack, prescription and pharmacist/prescriber review.
  • Abrupt cessation may worsen myocardial ischaemia. Do not self-stop, make up, reduce, alternate days or rotate with an extended-release tablet because of a pulse, blood-pressure value, dizziness or one missed use.
  • Bradycardia, hypotension, syncope, a fall, breathing difficulty, worsening heart failure or chest pain needs timely local clinical review; use local emergency pathways for severe symptoms.

Reviewed presentation examples — compare every field

  • Metoprolol tartrate 12.5 mg per tablet; 30-tablet bottleNDC 30698-460-03
  • Metoprolol tartrate 12.5 mg per tablet; 60-tablet bottleNDC 30698-460-01
  • Metoprolol tartrate 12.5 mg per tablet; 1000-tablet bottleNDC 30698-460-10

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-09-04
Source record
5 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image